Paras P. Vakharia

Paras P. Vakharia

Auto-generated profile, based on publicly available information

Paras P. Vakharia

Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2020 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
JSJonathan Silverberg
Jonathan Silverberg
DLD. Lei
D. Lei
MYM. Yousaf
M. Yousaf
SJS.R. Janmohamed
S.R. Janmohamed
PVP.P. Vakharia
P.P. Vakharia
DHD.Y. Hsu
D.Y. Hsu


24 April 2021 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
SLS. Lopez
S. Lopez
PVP. Vakharia
P. Vakharia
TVT. Vandergriff
T. Vandergriff
EFE.E. Freeman
E.E. Freeman
RVR. Vasquez
R. Vasquez
Dear Editor: Pernio‐like acral lesions are a common dermatologic manifestation reported after SARS‐CoV‐2 (COVID‐19) infection1,2. The pernio‐like eruption characteristically seen on the feet has been coined “COVID toes”. These lesions are more often seen in mild to asymptomatic patients and represent a late manifestation of COVID‐19 infection1. Here, we present a case of pernio that appeared after the Pfizer BNT162b1 COVID‐19 vaccine, in an asymptomatic patient with negative polymerase chain reaction (PCR) testing.

1 September 2020 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
JSJonathan Silverberg
Jonathan Silverberg
DLDonald Lei
Donald Lei
MYMuhammad Yousaf
Muhammad Yousaf
SJSherief R. Janmohamed
Sherief R. Janmohamed
PVParas P. Vakharia
Paras P. Vakharia
DHDerek Y. Hsu
Derek Y. Hsu

1 December 2024 in JAPhA Pharmacotherapy
Verified
Journal Article
Open access
MGMargaret E. Greer
Margaret E. Greer
PVParas P. Vakharia
Paras P. Vakharia
MMMelissa M. Mauskar
Melissa M. Mauskar

1 May 2017 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
PDF file
PVP. Vakharia
P. Vakharia
RCR. Chopra
R. Chopra
RSR. Sacotte
R. Sacotte
NPN. Patel
N. Patel
SIS. Immaneni
S. Immaneni
JSJonathan Silverberg
Jonathan Silverberg
Adult-onset atopic dermatitis (AD) has been reported to occur commonly. However, little is known about the risk factors and clinical characteristics of adult-onset AD. We performed a prospective study of 260 adults with AD to determine the associations and clinical characteristics of adult-onset disease. Personal and family history of atopic disease, signs and symptoms of AD were assessed by questionnaire and physical exam. Overall, 108 (45.4%) reported AD-onset during adulthood and 75 (28.8%) after age 50 yrs. Adult- vs. childhood-onset AD was associated with birthplace outside the US (chi square, P=0.02), but not sex, race/ethnicity, current smoking or alcohol consumption (P≥0.14); and significantly decreased personal or family history of asthma, hay fever and food allergy (P≤0.002 for all). Adult-onset AD was associated with lower Eczema Area and Severity Index (Mann-Whitney U test, P=0.008), Scoring AD (P=0.009), body surface area (P=0.003), but not Numerical Rating Scale-itch and sleep or Patient Oriented Eczema Measure (P≥0.38 for all). Latent Class Analysis identified 3 classes: 1. high probability of xerosis and intermediate probabilities of flexural or hand dermatitis; 2. high probability of xerosis, flexural, head, neck and hand dermatitis; 3. highest probabilities of all signs and symptoms. Adult-onset AD was associated with class 1 (multivariate logistic regression; aOR [95% CI]: 4.42 [1.16-16.89]) and 2 (aOR [95% CI]: 3.25 [1.22-8.65]). In conclusion, adults with AD have high rates of self-reported adult-onset and distinct phenotypes.